| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Therapeuticsmd, Inc. (TXMD) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. TXMD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 67.5K | $133.6K | - | |
| ? | 23.2K | $45.9K | - | |
| ? | 8.5K | $16.8K | - | |
| ? | 8.5K | $16.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2018 | Finizio Robert G | CEO | Sale+OE | 184,000 | $4.59 | $844,192.00 | -0.5% | |
| Dec 6, 2018 | Cartwright Daniel A | CFO | Sale+OE | 40,000 | $4.57 | $182,800.00 | -50.0% | |
| Dec 6, 2018 | Milligan John C.K. IV | President/ Secretary | Sale+OE | 258,000 | $4.77 | $1,231,692.00 | -8.1% | |
| Dec 3, 2018 | Bernick Brian | Director | Sale+OE | 182,800 | $5.07 | $926,796.00 | -1.4% | |
| Nov 29, 2018 | Milligan John C.K. IV | President/ Secretary | Sale+OE | 258,128 | $4.96 | $1,280,324.35 | -8.1% | |
| Nov 27, 2018 | Finizio Robert G | CEO | Sale+OE | 184,000 | $4.83 | $889,088.00 | -0.5% | |
| Nov 20, 2018 | Bernick Brian | Director | Sale+OE | 182,800 | $4.74 | $866,746.20 | -1.4% | |
| Nov 15, 2018 | Milligan John C.K. IV | President/ Secretary | Sale+OE | 258,000 | $4.90 | $1,265,232.00 | -8.1% | |
| Nov 13, 2018 | Finizio Robert G | CEO | Sale+OE | 184,000 | $4.77 | $877,588.00 | -0.5% | |
| Nov 9, 2018 | Bernick Brian | Director | Sale+OE | 182,800 | $4.88 | $891,332.80 | -1.4% |